CAR-T Therapies Should Impress EU Reimbursement Bodies

 
• By Ian Schofield
  
Benefit & Cost
EU reimbursement bodies are considering the cost-benefit of CAR-T therapies
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Market Access